Missing 30 minutes of sleep on weekdays linked to obesity, insulin resistance
the ONA take:
According to a preliminary findings presented Thursday at the annual meeting of the Endocrine Society in San Diego, California, researchers have found that missing just 30 minutes of sleep during weeknights could increase a person's weight and disrupt metabolism.
For the study, researchers enrolled 522 with newly diagnosed type 2 diabetes and randomly assigned them to usual care, added exercise, or diet and exercise.
When the study began, researchers found that those who did not get enough sleep on weeknights were 72% more likely to be obese than those who got sufficient sleep.
After 6 months, researchers found that participants who did not get sufficient sleep were more likely to be obese and have problems with blood sugar.
Specifically, researchers found that missing just 30 minutes of sleep during weeknights was enough to cause issues. For every 30 minutes of sleep missed on weekdays, the risk of obesity was increased by 17% and the risk of insulin resistance was elevated by 39%.
Missing just 30 minutes of sleep during weeknights could increase a person's weight and disrupt metabolism.
- Ixazomib, a New PI, Offers Improved Efficacy With Acceptable Toxicity Profile for Relapsed/Refractory Multiple Myeloma
- Acupuncture May Improve Fatigue in Patients with Lung Cancer
- "Light" Cigarettes and Cancer Risk (Fact Sheet)
- A Review of CDK4/6 Toxicities and Interactions Management in Breast Cancer
- Vitamin D3 Supplementation Has No Impact on Breast Density Percentage, Breast Cancer Risk
- Dexamethasone-Induced Hiccups in Chemotherapy May be Prevented by Rotating to Methylprednisolone
- New Evidence Shows Metastases May Spread Independently of Lymph Nodes
- Long Term Survivors of Prostate Cancer Express Treatment Decision Regret for Up to 15 Years
- FDA Expands Clearance for Cooling Cap Use With Chemotherapy for Solid Tumors
- Recommendations for Vaccine Administration During Chemotherapy
- Palliative Cancer Care Should Focus on Symptoms, Not Diagnoses
- COX-2 Inhibitors Can Improve Response to Immunotherapy of Some Cancer Tumors
- Risk for Prostate Cancer Not Associated With Vasectomy, Meta-analysis Affirms
- Disease-Free Survival After Breast Cancer Comparable With Exemestane, Sequential Tamoxifen/Exemestane
- Treating the Other "Patient": Depressive Symptoms Are Predictive of Declining Physical Health in Caregivers
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|